LOMBARD MEDICAL, INC. Lombard Medical, Inc. and MicroPort Scientific Corporation announced strategic partnership and significant infusion of capital into Lombard Medical by MicroPort. This partnership will allow Lombard Medical to accelerate commercialization in key global markets with its two key products: Aorfix™, the only stent graft to hold global approvals to treat abdominal aortic aneurysms with aortic neck angles up to 90 degrees, and Altura, a highly innovative stent graft that offers a simple and predictable treatment option for standard AAA anatomy. The agreement provides MicroPort the exclusive marketing rights for Lombard Medical's Aorfix and Altura AAA stent graft product lines in China, as well as the right to a technology license to manufacture the products for the China market.
Lombard Medical and MicroPort will also enter into component supply manufacturing agreement whereby MicroPort will manufacture in its facilities in Shanghai certain components for the Aorfix and Altura product lines. MicroPort will also have exclusive marketing rights for both Altura and Aorfix in Brazil.
